Oxford Nanopore Surges on New CBO Leadership, Eyes Expanded Genomics Partnerships
Oxford Nanopore’s stock jumps 4.6% after appointing former Philips strategist Sebastian Kronmueller as CBO, sparking fresh partnership prospects and a bullish outlook for next‑gen sequencing.
- OXFORD NANOPORE TECHNOLOGIES
- United Kingdom
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read